| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
868,994 |
|
|
Indirect Shares
|
241,951 |
|
|
| Direct
Value |
$900,729,661 |
|
|
|
Indirect Value
|
$250,787,051 |
|
|
| Total
Shares |
1,110,945 |
|
|
| Total
Value |
$1,151,516,711 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-06-10 |
868,994 |
2024-06-10 |
241,951 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
147 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-02-15 |
4 |
OE |
$399.66 |
$69,030,474 |
D/D |
172,723 |
925,209 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2011-11-30 |
4 |
D |
$58.19 |
$8,304,993 |
D/D |
(142,722) |
926,983 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2011-11-30 |
4 |
OE |
$28.01 |
$5,602,000 |
D/D |
200,000 |
928,701 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-08-13 |
4 |
AS |
$625.00 |
$483,125 |
D/D |
(773) |
936,710 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-08-05 |
4 |
AS |
$600.06 |
$30,003,000 |
D/D |
(50,000) |
937,483 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-12-22 |
4 |
D |
$610.04 |
$189,171,574 |
D/D |
(310,097) |
1,019,653 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Pres Regeneron Labs |
• • – |
2013-12-16 |
4 |
D |
$272.73 |
$11,720,299 |
D/D |
(42,974) |
1,063,638 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres Regen Res Labs |
• • – |
2012-12-17 |
4 |
D |
$179.13 |
$42,728,775 |
D/D |
(238,535) |
1,066,484 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2013-12-19 |
4 |
OE |
$21.25 |
$99,981 |
D/D |
4,705 |
1,068,343 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-12 |
4 |
AS |
$317.82 |
$28,504,985 |
D/D |
(88,987) |
1,068,343 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2013-05-07 |
4 |
S |
$261.66 |
$26,263,581 |
D/D |
(100,000) |
1,106,395 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Pres Regeneron Labs |
• • – |
2013-12-12 |
4 |
D |
$273.06 |
$2,561,849 |
D/D |
(9,382) |
1,106,612 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Pres Regeneron Labs |
• • – |
2013-12-12 |
4 |
OE |
$260.44 |
$2,499,964 |
D/D |
9,599 |
1,115,994 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres Regen Res Labs |
• • – |
2012-12-19 |
4 |
OE |
$9.49 |
$699,978 |
D/D |
50,846 |
1,117,330 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-11 |
4 |
D |
$314.31 |
$31,580,612 |
D/D |
(100,476) |
1,157,330 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-12-22 |
4 |
OE |
$179.13 |
$97,775,813 |
D/D |
442,267 |
1,169,835 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2013-05-06 |
4 |
D |
$260.44 |
$26,888,607 |
D/D |
(103,243) |
1,206,395 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-11 |
4 |
OE |
$9.49 |
$1,798,004 |
D/D |
189,463 |
1,257,806 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres Regen Res Labs |
• • – |
2012-12-14 |
4 |
D |
$179.13 |
$6,876,980 |
D/D |
(38,391) |
1,294,650 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres Regen Res Labs |
• • – |
2012-12-17 |
4 |
OE |
$109.29 |
$1,133,228 |
D/D |
10,369 |
1,304,811 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2013-05-06 |
4 |
OE |
$13.00 |
$2,500,004 |
D/D |
192,308 |
1,309,638 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres REGN Res Lab |
• • – |
2012-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
1,333,041 |
0 |
- |
|
147 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
